Medical Education and Grants

We measure ourselves by the impact we have on people with cancer and rare diseases.
Let’s continue to innovate.

Let’s advance science together

SpringWorks supports corporate memberships, medical education, and sponsorships to educate healthcare providers across the multidisciplinary team and advance medical care and scientific research for people with severe rare diseases and cancer. SpringWorks accepts both non-solicited grant requests within our areas of educational interest and solicited grant requests in response to our listed Request for Proposals. Grant requests are reviewed on a rolling basis throughout the calendar year, funding permitting.

Applicant and Grant Funding Types

Additional information on SpringWorks types of support:

Corporate Membership: Funding to medical or scientific professional organizations or societies, patient advocacy organizations, or trade organizations intended to establish a medical or scientific partnership.

Medical Education: Funding to medical schools or teaching hospitals, medical or scientific societies, patient advocacy organizations, medical education communication companies, or other medical education providers intended for independent medical education (IME), including, but not limited to, accredited independent medical education (CME/CE).

Sponsorship: Funding to medical schools or teaching hospitals, medical or scientific professional organizations or societies, patient advocacy organizations, or other non-profit organizations intended to advance medical or scientific initiatives, including, but not limited to, medical or scientific congress or meeting support, exhibit space, product advertising, or promotional programs or activities.

SpringWorks does not support the following:

• Grants or programs that are not aligned with our areas of educational interest
• Programs that have already started or are in progress
• Grants to individuals or private physician practices or groups
• Direct items or awards of value to physicians or other healthcare providers
• Travel and lodging costs except when used for medical education provider staff or program faculty
• Grants for Investigator-Initiated Research (IIR); more information on our Investigator-Initiated Research may be found here
• Organizations or medical education providers who are currently listed on probation or
non-accredited by the Accreditation Council for Continuing Medical Education (ACCME®)
• Excluded individuals or entities from the Office of Inspector General (OIG) List of Excluded Individuals/Entities

Areas of educational interest

Desmoid Tumors

  • Multidisciplinary team referral and management for adults with desmoid tumors (DT) in the community for individualized and optimized care
  • Guideline recommendations for diagnosis and management of adults with DT, including monitoring for progression, when to initiate treatment, and preferred treatment regimens
  • Clinical trial design, efficacy, safety/tolerability, patient-reported outcomes, and dosing of systemic therapies for adults with DT
  • Adverse event management and monitoring for adults with DT treated with systemic therapies

Neurofibromatosis Type 1 Plexiform Neurofibromas 

  • Multidisciplinary team decision-making, referral, and management for pediatric and adult patients with neurofibromatosis type 1 plexiform neurofibromas (NF1-PN)
  • The patient journey of adults with NF1-PN, including symptoms experienced by adults with NF1-PN, and the current challenges for adults with NF1-PN and healthcare providers (physicians, advanced practice providers, nurses, care coordinators, etc.), including unmet needs
  • Clinical trial design, primary/secondary endpoints, response rate, patient-reported outcomes, adverse events, and safety/tolerability of system therapies for patients with NF1-PN
  • Guideline recommendations for systemic therapy utilization for pediatric and adult patients with NF1-PN
  • AE management and supportive care of pediatric and adult patients with NF1-PN treated with systemic therapies

Submission details

SpringWorks uses the CyberGrants application management system. You may access and apply for grant funding here. SpringWorks has created a Guide and Checklists to ensure that all required supporting documentation and related information are provided by those seeking Corporate Funding.

SpringWorks follows regulatory policies outlined by the Office of Inspector General (OIG) Compliance Guidelines, the U.S. Food and Drug Administration’s (FDA) guidance regarding industry-supported scientific and educational activities, and the Accreditation Council for Continuing Medical Education (ACCME®). Under federal and state laws, SpringWorks must track and disclose certain expenditures directed to healthcare providers under the Centers for Medicare & Medicaid Services (CMC), National Physician Payment Transparency Program (“Sunshine Act” or “Open Payments”) as applicable for payments or transfers of value to physicians or US-based teaching hospitals. External funding by SpringWorks is not provided as an incentive to recommend or prescribe a SpringWorks product. SpringWorks Therapeutics reserves the right to change the classification of a grant request to align with established company definitions.

Please take time to consider how your program fits within established laws, regulations, and guidelines before submitting a request.

For questions regarding grants and funding policies, or to request information on the status of a grant request, please contact us at grants@springworkstx.com.